glp-1 and pancreas GLP-1–Based Therapies: The Dilemma of Uncertainty GLP-1: Actions on Beta-cell Mass

With the recent announcement that the shortage of Ozempic and Wegovy is officially over, the FDA has declared that compounding pharmacies must stop producing and selling compounded semaglutide by May 22, 2025

If you are part of the roughly 12 percent of adults in the United States currently taking a GLP-1 medication for weight loss or to manage your type 2 diabetes

Each bottle provides 30 servings for a full month of metabolic and digestive support

Some dentists are calling for routine dental evaluations before starting these medications, similar to protocols for bisphosphonate therapy

NASM is ensuring trainers are ready for this evolution with our evidence-based Understanding Weight Loss Medications Course: The industry is evolving